Neural Network Metastasis Detection Using ADC Maps

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current clinical practices for metastatic characterization in cancer staging, particularly for lymph node and distant metastasis, face challenges such as inaccurate manual annotation, the 'flare' phenomenon, and high variability in lesion characteristics, leading to suboptimal accuracy in N-stage determination and metastasis detection.

Innovation Solution

A computer-implemented method using a deep convolutional neural network with attention gates, trained on apparent diffusion coefficient (ADC) maps from diffusion-weighted MRI measurements, to automate the detection and characterization of metastases, providing spatial context and improving prediction reliability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If manual annotation is used for metastasis detection, then flexibility and adaptability are maintained, but accuracy and reliability deteriorate due to human error and variability

Engineering Contradiction:
Improvemetastasis detection accuracyVSAvoidannotation process complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system enables automated self-annotation through neural networks that automatically detect and characterize metastases in MRI images, eliminating the need for manual annotation by radiologists while maintaining or improving accuracy through consistent algorithmic application

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent replaces the manual mechanical annotation process with an automated neural network system that processes MRI images and generates metastasis detections algorithmically, substituting human manual work with computational automation

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Difficulty of detecting and measuring

If contrast-enhanced MRI with diffusion weighted imaging is used, then detection capability is improved, but the 'flare' phenomenon and lesion variability increase measurement precision challenges

Engineering Contradiction:
Improvemetastasis detection capabilityVSAvoidlesion characterization accuracy
Core Design Contradiction:
Difficulty of detecting and measuringVSMeasurement precision

Solution Approach 1:

The neural network analyzes multiple MRI parameters including contrast enhancement patterns and diffusion weighted imaging metrics simultaneously, transforming multiple imaging parameters into a unified metastasis characterization that overcomes the limitations of individual parameter variability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces radiomics features as intermediary variables that bridge the gap between raw MRI imaging data and metastasis characterization, extracting quantitative features that serve as reliable intermediaries for accurate detection despite imaging variability

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If deep neural networks are trained on multiple MRI parameters including ADC maps, then measurement precision and reliability are improved, but device complexity and computational requirements increase

Engineering Contradiction:
Improvemetastatic characterization reliabilityVSAvoidneural network complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The neural network is structured with multiple specialized layers including convolutional layers for feature extraction, attention gates for spatial prioritization, and separate processing streams for different MRI parameters, segmenting the complex task into manageable functional components

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent incorporates 3D spatial information and temporal sequence data from multiple MRI sequences into the neural network architecture, adding dimensional depth to the analysis that improves reliability while managing complexity through hierarchical processing

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Data Source

PatentUS20240324963A1Metastatic characterization using neural network and appar-ent diffusion coefficient map
Publication Date: 2024.10.03 SIEMENS HEALTHINEERS AG
  • US20240324963A1 patent drawing
  • US20240324963A1 patent drawing

AI summary

Various examples of the disclosure pertain to the characterization of one or more metastases using a neural network, as well as an apparent diffusion coefficient, ADC, map as obtained from diffusion-weighted magnetic resonance imaging, DWI MRI. A convolutional neural network can be employed. Training processes and inference processes are disclosed.